SEC FORM
3
SEC Form 3
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
|
| OMB APPROVAL |
| OMB Number: |
3235-0104 |
| Estimated average burden |
| hours per response: |
0.5 |
|
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year)
09/06/2016
|
3. Issuer Name and Ticker or Trading Symbol
CRYOLIFE INC
[ CRY ]
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
Director |
|
10% Owner |
| X |
Officer (give title below) |
|
Other (specify below) |
| SVP, CHRO |
|
5. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
| X |
Form filed by One Reporting Person |
|
Form filed by More than One Reporting Person |
|
| Table I - Non-Derivative Securities Beneficially Owned |
|---|
| 1. Title of Security (Instr.
4)
|
2.
Amount of Securities Beneficially Owned (Instr.
4)
|
3. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
4. Nature of Indirect Beneficial Ownership (Instr.
5)
|
| Common Stock |
3,396
|
D |
|
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
|
|---|
| 1. Title of Derivative Security (Instr.
4)
|
2. Date Exercisable and Expiration Date
(Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr.
4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
6. Nature of Indirect Beneficial Ownership (Instr.
5)
|
| Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
| Stock Option |
09/09/2017
|
09/09/2023 |
Common Stock |
3,396 |
17.24 |
D |
|
| Explanation of Responses: |
|
|
|
/s/ J McDermid |
09/14/2016 |
|
** Signature of Reporting Person |
Date |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
| * If the form is filed by more than one reporting person,
see
Instruction
5
(b)(v). |
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
Exhibit 24
CONFIRMING STATEMENT
This Statement confirms that the undersigned has authorized and designated
the Chief Executive Officer, Chief Financial Officer, or the Corporate
Secretary of CryoLife, Inc. to execute and file on the undersigned's behalf
all Forms 3, 4 and 5 (including any amendments thereto) that the
undersigned may be required to file with the U.S. Securities and Exchange
commission as a result of the undersigned's ownership of or transactions
in securities of CryoLife, Inc. The authority of the Chief Executive
Officer, Chief Financial Officer, or the Corporate Secretary of CryoLife,
Inc. under this Statement shall continue until the undersigned is no longer
required to file Forms 3, 4 and 5 with regard to the undersigned's
ownership of or transactions in securities of CryoLife, Inc., unless
earlier revoked in writing. The undersigned acknowledges that the Chief
Executive Officer, Chief Financial Officer, or the Corporate Secretary of
CryoLife, Inc. is not assuming any of the undersigned's responsibilities
to comply with Section 16 of the Securities Exchange Act of 1934.
Dated as of September 13, 2016 /s/ James McDermid
James McDermid
